AGARWALEYE
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contac… Read more
AGARWALEYE (AGARWALEYE) - Total Liabilities
Latest total liabilities as of September 2025: ₹17.67 Billion INR
Based on the latest financial reports, AGARWALEYE (AGARWALEYE) has total liabilities worth ₹17.67 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
AGARWALEYE - Total Liabilities Trend (2021–2025)
This chart illustrates how AGARWALEYE's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
AGARWALEYE Competitors by Total Liabilities
The table below lists competitors of AGARWALEYE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nowtransit Inc
PINK:NOTR
|
USA | $132.92K |
|
FastPartner AB Series D
ST:FPAR-D
|
Sweden | Skr21.51 Billion |
|
GMR Power and Urban Infra Limited
NSE:GMRP&UI
|
India | ₹150.30 Billion |
|
Xinlei Compressor Co. Ltd. A
SHE:301317
|
China | CN¥1.03 Billion |
|
Telecom Argentina S.A
PINK:TCMFF
|
USA | $9.09 Trillion |
|
DongKook Pharmaceutical Co. Ltd
KQ:086450
|
Korea | ₩293.92 Billion |
|
Inst Diagnosti
SN:INDISA
|
Chile | CL$191.22 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down AGARWALEYE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AGARWALEYE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AGARWALEYE (2021–2025)
The table below shows the annual total liabilities of AGARWALEYE from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹17.45 Billion | +25.57% |
| 2024-03-31 | ₹13.89 Billion | +19.16% |
| 2023-03-31 | ₹11.66 Billion | +47.18% |
| 2022-03-31 | ₹7.92 Billion | +34.68% |
| 2021-03-31 | ₹5.88 Billion | -- |